BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10233632)

  • 1. Ulceration associated with stable myelodysplastic syndrome: atypical pyoderma gangrenosum?
    Harris A; O'hea AM; Burge S
    Clin Exp Dermatol; 1998 Nov; 23(6):293-5. PubMed ID: 10233632
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloid sarcoma developing in pre-existing pyoderma gangrenosum.
    Kristensen IB; Møller H; Kjaerskov MW; Yderstraede K; Møller MB; Bergmann OJ
    Acta Derm Venereol; 2009; 89(2):175-7. PubMed ID: 19326005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pseudo-Pelger-Huët anomaly in pyoderma gangrenosum associated with myelodysplastic syndrome.
    Chiang M; Fleming M
    Am J Dermatopathol; 2007 Jun; 29(3):293-5. PubMed ID: 17519630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma gangrenosum: an inflammatory ulcer.
    Samuel J; Williams C
    J Wound Care; 1996 Jul; 5(7):314-8. PubMed ID: 8954419
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelodysplastic syndrome, pyoderma gangrenosum, and Crohn disease.
    Sandoval C
    J Pediatr Hematol Oncol; 2001 May; 23(4):259-60. PubMed ID: 11846312
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyoderma gangrenosum in hematologic malignancies: A systematic review.
    Montagnon CM; Fracica EA; Patel AA; Camilleri MJ; Murad MH; Dingli D; Wetter DA; Tolkachjov SN
    J Am Acad Dermatol; 2020 Jun; 82(6):1346-1359. PubMed ID: 31560977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapidly expanding ulcer. Myelodysplastic syndrome-associated (paraneoplastic) pyoderma gangrenosum.
    Srivastava M; Rencic A; Nousari HC
    Arch Dermatol; 2003 Apr; 139(4):531-6. PubMed ID: 12707106
    [No Abstract]   [Full Text] [Related]  

  • 8. Articular and pancreatic involvement in pyoderma gangrenosum associated with myelodysplastic syndrome.
    Ochiai T; Hara H; Shimojima H; Fujitsuka A; Morishima T; Yamazaki T; Sawada U
    Dermatology; 2002; 205(1):70-2. PubMed ID: 12145440
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyoderma gangrenosum with myelodysplastic syndrome treated with analogous bone marrow transplantation.
    Yamanaka K; Kuniyuki S; Maekawa N; Yoshida Y; Teshima H
    Acta Derm Venereol; 2009; 89(1):105-6. PubMed ID: 19197560
    [No Abstract]   [Full Text] [Related]  

  • 10. Concurrent pyoderma gangrenosum and infection with Scedosporium apiospermum.
    Tilakaratne D; Ryan E; Pearce A
    Australas J Dermatol; 2016 May; 57(2):e46-8. PubMed ID: 25920922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum.
    Hambin TJ
    Lancet; 1998 Apr; 351(9109):1134. PubMed ID: 9660611
    [No Abstract]   [Full Text] [Related]  

  • 12. Image Gallery: Pyoderma gangrenosum in a patient with myelodysplastic syndrome treated with azacitidine.
    Pardo Pastor J; Redondo Capafons S; March López P; Nicolás Picó J; Pineda A; Martí JM
    Br J Dermatol; 2017 Sep; 177(3):e68. PubMed ID: 28940271
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexistence of pustular and vegetative pyoderma gangrenosum in a patient with myelodysplastic syndrome.
    Omiya W; Ujiie H; Akiyama M; Izumi K; Shigematsu A; Onozawa M; Shimizu H
    Eur J Dermatol; 2012; 22(5):711-2. PubMed ID: 22858442
    [No Abstract]   [Full Text] [Related]  

  • 14. Bullous pyoderma gangrenosum in acute myeloid leukaemia.
    Wiseman DH; Hunter HJ; Dennis M
    Eur J Haematol; 2007 Jul; 79(1):91-2. PubMed ID: 17419746
    [No Abstract]   [Full Text] [Related]  

  • 15. Bullous pyoderma gangrenosum with chronic myelogenous leukemia: report of a case.
    Lewis JR
    Cutis; 1980 Jan; 25(1):82-3. PubMed ID: 6928121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum in a patient with myelodysplastic syndrome followed by possible extracutaneous manifestations in the gallbladder, liver, bone and lung.
    Matsumura Y; Nishiwaki F; Morita N; Kore-Eda S; Miyachi Y
    J Dermatol; 2011 Nov; 38(11):1102-1105. PubMed ID: 21434984
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of etoposide for pyoderma gangrenosum associated with myelodysplastic syndrome and trisomy 8: cytokine profiles during treatment.
    Fujiwara D; Hamada T; Yamasaki O; Sando Y; Saeki K; Fujii N; Kawakami Y; Iwatsuki K
    Eur J Dermatol; 2017 Oct; 27(5):525-527. PubMed ID: 28943508
    [No Abstract]   [Full Text] [Related]  

  • 18. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia.
    Fox LP; Geyer AS; Husain S; Grossman ME
    Leuk Lymphoma; 2006 Jan; 47(1):147-50. PubMed ID: 16321840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with ustekinumab and vacuum-assisted closure therapy in recalcitrant myelodysplastic syndrome-associated pyoderma gangrenosum: case report and literature review.
    Nieto D; Sendagorta E; Rueda JM; Herranz P
    Clin Exp Dermatol; 2019 Jan; 44(1):116-119. PubMed ID: 29851121
    [No Abstract]   [Full Text] [Related]  

  • 20. Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome.
    Korekawa A; Nakajima K; Nakano H; Sawamura D
    J Dermatol; 2022 Apr; 49(4):e131-e132. PubMed ID: 34862670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.